thuringiensin: RN given refers to parent cpd
ID Source | ID |
---|---|
PubMed CID | 20056441 |
SCHEMBL ID | 118874 |
MeSH ID | M0186845 |
Synonym |
---|
thuringiensin |
beta-exotoxin (bacillus thuringiensis) |
d-allaric acid, o-5'-deoxyadenosinyl-(5'-4)-o-3,6-anhydro-alpha-d-glucopyranosyl-(1-2)-, 4-(dihydrogenphosphate) |
nsc 197177 |
bacillus thuringiensis exotoxin |
thuringiensin a |
d-allaric acid, 2-o-alpha-d-glucopyranosyl-, 4-(dihydrogen phosphate), 4'-5'-anhydride with adenosine |
thurintox |
2-[(2r,3r,4r,5s,6r)-5-[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid |
turingin-1 [russian] |
unii-jbu770v87c |
turingin-1 |
d-allaric acid, o-5'-deoxyadenosin-5'-yl-(5'.fwdarw.4)-o-alpha-d-glucopyranosyl-(1.fwdarw.2)-, 4-(dihydrogen phosphate) |
jbu770v87c , |
SCHEMBL118874 |
.beta.-exotoxin (bacillus thuringiensis) |
d-allaric acid, o-5'-deoxyadenosin-5'-yl-(5'->4)-o-.alpha.-d-glucopyranosyl-(1->2)-, 4-(dihydrogen phosphate |
(2r,3s,4s,5s)-2-[(2r,3r,4r,5s,6r)-5-[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid |
Q27281428 |
Thuringiensin is a thermostable secondary metabolite in Bacillus thuringiensis and has insecticidal activity against a wide range of insects.
Excerpt | Reference | Relevance |
---|---|---|
"Thuringiensin is a thermostable secondary metabolite in Bacillus thuringiensis and has insecticidal activity against a wide range of insects. " | ( Genome-wide screening reveals the genetic determinants of an antibiotic insecticide in Bacillus thuringiensis. Cao, SY; Hu, ZF; Liu, XY; Liu, Y; Peng, DH; Ruan, LF; Sun, M; Yu, ZN; Zheng, JS, 2010) | 1.8 |
Excerpt | Reference | Relevance |
---|---|---|
" The strains were of serotype H-1, producing thuringiensin, toxic to flies, and serotype H-14, producing endotoxin, toxic to mosquitoes, but not thuringiensin." | ( Safety testing of Bacillus thuringiensis preparations, including thuringiensin, using the Salmonella assay. Abdel-Hameed, AH; Carlberg, G; Tikkanen, L, 1995) | 0.79 |
Excerpt | Relevance | Reference |
---|---|---|
" The dosage of 360 units/mL penicillin-G had only a modest effect on the growth of the microorganism." | ( Penicillin-G enhanced production of thuringiensin by Bacillus thuringiensis sp. darmstadiensis. Tzeng, YM; Young, YH, ) | 0.41 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (26.47) | 18.2507 |
2000's | 20 (58.82) | 29.6817 |
2010's | 5 (14.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.16) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (2.78%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 35 (97.22%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |